IMNM

Immunome Inc

• TipRanks·4d ago

  Immunome Expands Oncology Pipeline With New Phase 1 IM-1617 Trial

• TipRanks·6d ago

  Top Immunome Insider Makes Bold New Stock Move

• PUBT·05/19 11:57

  Immunome director Jean Jacques Bienaime buys 5,000 shares for $103,500

• TipRanks·05/16 14:36

  LifeSci Capital Keeps Their Buy Rating on Immunome (IMNM)

• Dow Jones·05/15 17:48

  Immunome Is Maintained at Outperform by Leerink Partners

• Dow Jones·05/15 17:48

  Immunome Price Target Cut to $33.00/Share From $37.00 by Leerink Partners

• TipRanks·05/15 10:26

  Immunome price target lowered to $33 from $37 at Leerink

• TipRanks·05/14 14:51

  Analysts Offer Insights on Healthcare Companies: Immunome (IMNM), Aveanna Healthcare Holdings (AVAH) and QT Imaging Holdings (QTI)

• TipRanks·05/14 13:15

  Immunome Price Target Maintained at $35 as Analyst Sees Best-in-Class Potential for Varegacestat in Desmoid Tumors

• TipRanks·05/14 08:07

  Wedbush Remains a Buy on Immunome (IMNM)

• TipRanks·05/13 14:50

  Analysts Are Bullish on These Healthcare Stocks: Immunome (IMNM), Coherus Biosciences (CHRS)

• TipRanks·05/13 13:40

  Analysts Conflicted on These Healthcare Names: Kyverna Therapeutics, Inc. (KYTX), Immunome (IMNM) and Prime Medicine, Inc. (PRME)

• TipRanks·05/13 11:46

  Piper Sandler Remains a Buy on Immunome (IMNM)

• TipRanks·05/13 11:37

  Immunome (IMNM) Gets a Buy from Guggenheim

• Benzinga·05/13 11:11

  HC Wainwright & Co. Reiterates Buy on Immunome, Maintains $40 Price Target